Shukra Pharmaceuticals Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

39.98 -1.26 (-3.06%)Updated : 18 Feb 2026

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	86.77	77.84	74.97	35.11
Accumulated Depreciation Total	-24.39	-	-	-
Other Liabilities Total	0.13	0.11	0.11	-
Accrued Expenses	1.05	-	-	-
Long Term Debt	3.11	2.66	3.77	3.13
Common Stock Total	43.79	10.94	3.91	1.57
Other Equity Total	0.00	46.69	21.38	14.78
Other Current Assets Total	1.36	17.10	13.22	1.11
Prepaid Expenses	0.01	-	-	-
Total Assets	86.77	77.84	74.97	35.11
Current Portof LT Debt/ Capital Leases	1.06	0.50	1.31	0.25
Additional Paid- In Capital	4.74	0.00	-	-
Cash	12.12	9.98	3.97	0.09
Total Equity	62.84	57.64	25.30	16.35
Retained Earnings( Accumulated Deficit)	14.31	-	-	-
Total Common Shares Outstanding	43.79	43.79	6.26	30.09
Property/ Plant/ Equipment Total- Gross	45.73	-	-	-
Tangible Book Valueper Share Common Eq	1.44	1.32	4.04	0.54
Total Liabilities	23.93	20.20	49.67	18.76
Total Debt	4.18	3.15	5.08	3.38
Cashand Short Term Investments	12.12	9.98	3.97	0.09
Total Receivables Net	37.80	26.83	32.72	10.52
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Deferred Income Tax	3.41	3.27	3.29	3.26
Accounts Receivable- Trade Net	27.44	24.51	30.19	7.40
Property/ Plant/ Equipment Total- Net	21.34	21.60	21.89	19.24
Total Current Liabilities	17.28	14.15	42.51	12.38
Total Inventory	14.14	2.31	3.16	3.95
Accounts Payable	9.22	7.22	34.25	8.59
Other Currentliabilities Total	5.96	6.43	6.94	3.54
Total Long Term Debt	3.11	2.66	3.77	3.13
period Length	0.00	0.00	0.00	0.00
Total Current Assets	65.43	56.23	53.07	15.67
Long Term Investments	-	-	-	0.20